Netupitant
From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Lua error in Module:Infobox at line 314: malformed pattern (missing ']').
Netupitant is an antiemitic drug. In the United States, the combination drug netupitant/palonosetron (Akynzeo) is approved by the Food and Drug Administration for prevention of acute and delayed nausea and vomiting associated with cancer chemotherapy.[1]
Mechanism of action
Netupitant is a selective NK1 receptor antagonist.[2]
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
5-HT3 Serotonin ion channel antagonists |
|||||||||
---|---|---|---|---|---|---|---|---|---|
5-HT Serotonin G-protein receptor antagonists |
|||||||||
CB1 Agonists (Cannabinoids) |
|||||||||
D2/D3 Antagonists | |||||||||
H1 antagonists (Antihistamines) |
|||||||||
mACh antagonists (Anticholinergics) |
|
||||||||
NK1 Antagonists | |||||||||
Others | |||||||||
|
<templatestyles src="Asbox/styles.css"></templatestyles>
![]() |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
Categories:
- Pages with reference errors
- Infobox drug articles without a structure image
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Articles containing unverified chemical infoboxes
- Antiemetics
- NK1 receptor antagonists
- Organofluorides
- Piperazines
- Pharmacology stubs
Hidden categories: